ArticleFrontiers in plant science2025
Few-shot crop disease recognition using sequence- weighted ensemble model-agnostic meta-learning.
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lightweight Cross-Domain Few-Shot Plant Disease Recognition Through Target-Domain Statistical Calibration.Sensors (Basel, Switzerland) · 2026Article
- BLAP: lesion-aware adaptive multi-scale visual prompt tuning for few-shot crop disease diagnosis.Frontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diseases pose significant threats to crop production, leading to substantial yield reductions and jeopardizing global food security. Timely and accurate detection of crop diseases is essential for ensuring sustainable agricultural development and effective crop management. While deep learning-based computer vision techniques have emerged as powerful tools for crop disease recognition, these methods are heavily reliant on large datasets, which are often difficult to obtain in practical agricultural settings. This challenge highlights the need for models capable of learning from limited data, a scenario known as the few-shot learning problem. In this paper, we introduce a novel few-shot learning approach, the Sequence-Weighted Ensemble Model-Agnostic Meta-Learning (SWE-MAML), designed to train crop disease recognition models with minimal sample sizes. The SWE-MAML framework employs meta-learning to sequentially train a set of base learners, followed by a weighted sum of their predictions for classifying plant disease images. This method integrates ensemble learning with Model-Agnostic Meta-Learning (MAML), allowing the effective training of multiple classifiers within the MAML framework. Experimental results show that SWE-MAML demonstrates strong competitiveness compared to state-of-the-art algorithms on the PlantVillage dataset. Compared to the original MAML, SWE-MAML improves accuracy by 3.75%-8.59%. Furthermore, we observe that the number of base learners significantly influences model performance, with an optimal range of 5-7 learners. Additionally, pre-training with a larger number of disease classes enhances the model's ability to recognize "unseen" classes. SWE-MAML was also applied to a real-world few-shot potato disease recognition task, achieving an accuracy of 75.71% using just 30 images per disease class in the support set. These findings validate that SWE-MAML is a highly effective solution for the few-shot recognition of crop diseases, offering a promising approach for practical deployment in agricultural settings where data scarcity is a major challenge. The integration of ensemble learning with meta-learning enables high-performance disease recognition with minimal data, marking a significant advancement in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.